November 29, 2021

Volume XI, Number 333

Advertisement
Advertisement

November 29, 2021

Subscribe to Latest Legal News and Analysis
Advertisement

Drug Use Among U.S. Workers Declines 74% Over Past 25 Years, But Amphetimine and Opiate Use Grows

Quest Diagnostics’ 25th Anniversary Drug Testing Index reports a deep drop in drug use among American workers in the quarter century the Index has been published.  Based on over 125 urinalysis drug tests, the laboratory network and provider of diagnostic information said use had plummeted 75% since its data assessment initiative began shortly after passage of the 1988 federal Drug Free Workplace Act through 2012.  Among the more significant findings announced by Quest on November 18  http://www.questdiagnostics.com/home/physicians/health-trends/drug-testing:

  • “The positivity rate for the combined U.S. Workforce dropped from 13.6% in 1988 to 3.5% in 2012 (74%).

  • The positivity rate for the Federally Mandated Safety-Sensitive Workforce declined by 38% from 2.6% in 1992 to 1.6% in 2012.

  • The positivity rate for the U.S. General Workforce declined by 60%, from 10.3% in 1992 to 4.1% in 2012.”

Despite the overall decline, the positivity rate for certain drugs rose during this period.  Quest reports:

  • “Positivity rates for amphetamines (including amphetamine and methamphetamine) nearly tripled (196% higher) in the combined U.S. workforce and, in 2012, were at the highest level since 1997.  The positivity rate for amphetamine itself, including prescription medications such as Adderall®, has more than doubled in the last 10 years.

  • Positivity rates for prescription opiates, which includes the drugs hydrocodone, hydromorphine, oxycodone and oxymorphine, have also increased steadily over the last decade—more than doubling for hydrocodone and hydromorphine and up 71% for oxycodone—reflective of national prescribing trends.”

2012 report by Quest Diagnostics found that the majority of Americans misused their prescription medications, including opioids and amphetamine medications. 

The data suggests, in our opinion, that workplace drug testing, with its threat of disclosure and risk of disciplinary action and termination, has helped reduce markedly the positivity rates for illegal drugs over the last 25 years, but that employers’ testing programs must be reviewed periodically and revised to address the abuse of new and different drugs and controlled substances, and changes in laws and regulations.

Jackson Lewis P.C. © 2021National Law Review, Volume III, Number 339
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

Roger Kaplan employee drug testing attorney, Jackson Lewis Law Firm
Principal

Roger S. Kaplan is a Principal in the Long Island, New York, office of Jackson Lewis P.C. He has worked with many employers to help assure their drug and abuse testing policies and procedures comply with the state and federal laws and to develop effective testing strategies. He has frequently addressed business and professional groups on substance abuse testing issues.

Mr. Kaplan has represented clients and appeared before executive departments and administrative agencies, such as the United States Department of Labor (...

631-247-4611
Advertisement
Advertisement
Advertisement